tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Ratios

Compare
362 Followers

Keros Therapeutics Ratios

KROS's free cash flow for Q4 2025 was $-0.04. For the 2025 fiscal year, KROS's free cash flow was decreased by $ and operating cash flow was $-75.81. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
15.45 15.45 21.45 14.25 17.27
Quick Ratio
15.45 15.45 21.45 14.25 17.27
Cash Ratio
14.08 14.08 20.40 13.59 16.86
Solvency Ratio
2.54 2.54 -4.20 -4.02 -3.54
Operating Cash Flow Ratio
5.27 5.27 -5.86 -5.11 -4.23
Short-Term Operating Cash Flow Coverage
44.64 44.64 0.00 0.00 0.00
Net Current Asset Value
$ 280.55M$ 280.55M$ 544.56M$ 309.48M$ 256.41M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.03 0.04 0.04
Debt-to-Equity Ratio
0.06 0.06 0.03 0.04 0.05
Debt-to-Capital Ratio
0.05 0.05 0.03 0.04 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.12 1.12 1.08 1.11 1.11
Debt Service Coverage Ratio
32.33 27.93 0.00 0.00 -104.00K
Interest Coverage Ratio
0.00 0.00 0.00 0.00 -114.79K
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.45 0.45 0.50 0.49 0.53
Net Debt to EBITDA
-3.27 -3.75 2.91 2.08 2.56
Profitability Margins
Gross Profit Margin
99.52%99.38%100.00%100.00%0.00%
EBIT Margin
33.28%28.94%-5269.10%-101319.21%0.00%
EBITDA Margin
33.90%29.55%-5234.48%-100779.47%0.00%
Operating Profit Margin
28.94%28.94%-5938.96%-112543.71%0.00%
Pretax Profit Margin
37.65%37.65%-5269.10%-101319.21%0.00%
Net Profit Margin
35.65%35.65%-5277.55%-101319.21%0.00%
Continuous Operations Profit Margin
35.65%35.65%-5277.55%-101319.21%0.00%
Net Income Per EBT
94.69%94.69%100.16%100.00%100.00%
EBT Per EBIT
130.12%130.12%88.72%90.03%91.19%
Return on Assets (ROA)
25.74%25.74%-30.42%-41.35%-34.12%
Return on Equity (ROE)
14.25%28.70%-32.78%-46.05%-37.73%
Return on Capital Employed (ROCE)
22.24%22.24%-35.83%-49.17%-39.55%
Return on Invested Capital (ROIC)
20.90%20.90%-35.71%-49.02%-39.49%
Return on Tangible Assets
25.74%25.74%-30.42%-41.35%-34.12%
Earnings Yield
21.04%11.48%-31.61%-13.07%-8.64%
Efficiency Ratios
Receivables Turnover
38.30 38.30 0.80 0.14 0.00
Payables Turnover
0.59 0.77 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
11.55 11.55 0.15 <0.01 0.00
Asset Turnover
0.72 0.72 <0.01 <0.01 0.00
Working Capital Turnover Ratio
0.49 0.57 <0.01 <0.01 0.00
Cash Conversion Cycle
-606.74 -466.25 458.15 2.64K 0.00
Days of Sales Outstanding
9.53 9.53 458.15 2.64K 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
616.27 475.78 0.00 0.00 0.00
Operating Cycle
9.53 9.53 458.15 2.64K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
2.89 2.89 -4.30 -4.23 -2.78
Free Cash Flow Per Share
2.85 2.85 -4.35 -4.31 -2.82
CapEx Per Share
0.04 0.04 0.05 0.08 0.05
Free Cash Flow to Operating Cash Flow
0.99 0.99 1.01 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
69.31 69.31 -83.31 -50.53 -56.46
Capital Expenditure Coverage Ratio
69.31 69.31 -83.31 -50.53 -56.46
Operating Cash Flow Coverage Ratio
6.37 6.37 -8.53 -8.62 -5.28
Operating Cash Flow to Sales Ratio
0.44 0.44 -45.32 -824.56 0.00
Free Cash Flow Yield
25.62%13.98%-27.47%-10.84%-5.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
4.76 8.71 -3.16 -7.65 -11.58
Price-to-Sales (P/S) Ratio
1.70 3.11 166.94 7.75K 0.00
Price-to-Book (P/B) Ratio
1.37 2.50 1.04 3.52 4.37
Price-to-Free Cash Flow (P/FCF) Ratio
3.91 7.15 -3.64 -9.22 -17.00
Price-to-Operating Cash Flow Ratio
3.85 7.05 -3.68 -9.40 -17.30
Price-to-Earnings Growth (PEG) Ratio
0.27 -0.06 0.82 -0.30 -0.18
Price-to-Fair Value
1.37 2.50 1.04 3.52 4.37
Enterprise Value Multiple
1.73 6.76 -0.28 -5.61 -9.10
Enterprise Value
143.00M 487.29M 51.57M 854.11M 946.29M
EV to EBITDA
1.73 6.76 -0.28 -5.61 -9.10
EV to Sales
0.59 2.00 14.53 5.66K 0.00
EV to Free Cash Flow
1.35 4.60 -0.32 -6.73 -13.27
EV to Operating Cash Flow
1.33 4.53 -0.32 -6.86 -13.51
Tangible Book Value Per Share
8.14 8.14 15.27 11.28 10.99
Shareholders’ Equity Per Share
8.14 8.14 15.27 11.28 10.99
Tax and Other Ratios
Effective Tax Rate
0.05 0.05 >-0.01 0.00 0.00
Revenue Per Share
6.56 6.56 0.09 <0.01 0.00
Net Income Per Share
2.34 2.34 -5.00 -5.20 -4.15
Tax Burden
0.95 0.95 1.00 1.00 1.00
Interest Burden
1.13 1.30 1.00 1.00 1.00
Research & Development to Revenue
0.53 0.53 48.91 895.75 0.00
SG&A to Revenue
0.19 0.19 11.48 230.69 0.00
Stock-Based Compensation to Revenue
0.12 0.12 9.82 190.48 0.00
Income Quality
1.24 1.24 0.86 0.81 0.67
Currency in USD